After Pfizer agreed to acquire weight-loss drug developer Metsera for $7.3 billion, Novo Nordisk swooped in with an ...

Live Updates Live Coverage Updates appear automatically as they are published. Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis ...

Key market opportunities in the pharma 5 sector include leveraging digital health technologies, AI-driven drug discovery, and ...

October's top ETF gainers included the likes of NVTX, AMUU, KORU, LABU and INTW. These ETFs soared as AI, crypto and reform ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...

Discover how the Magnificent 7 stocks and artificial intelligence demand fueled a record S&P 500 earnings surge in Q3 2025, driving market optimism and sector leadership.

The Score is a weekly review of the biggest stock moves and the news that drove them. Here are six stocks that drew the spotlight this week.

GPU semiconductor factory, Jensen Huang’s roadmap connects data centers, networks, and industrial systems into a ...

Recursion, Roche and Genentech unveiled the latest product of their nearly four-year artificial intelligence drug discovery collaboration. GSK ’s Blenrep was approved by the FDA for treatment of ...

NVIDIA CEO Jensen Huang is visiting South Korea to strengthen partnerships with Samsung, Hyundai, SK, and Naver, unveiling ...

Major stock indexes declined Thursday as investors digested several big tech earnings reports and awaited more after the ...